Clinical Trials Logo

Metabolic Diseases clinical trials

View clinical trials related to Metabolic Diseases.

Filter by:

NCT ID: NCT01723748 Completed - Acromegaly Clinical Trials

Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects

Start date: December 2012
Phase: N/A
Study type: Interventional

The treatment with SA still leaves some questions unanswered. Firstly, SA treatment often results in a concomitant suppression of the insulin secretion, which might lead to clinically significant glucose intolerance. Secondly, the traditional evaluation of disease activity by measuring circulating levels of GH and total IGF-I is not reliable enough Hypotheses: Treatment of acromegaly with SA versus surgery alone is associated with: - Glucose intolerance despite normalized insulin sensitivity - Modified peripheral GH activity in peripheral target organs assessed on molecular endpoints

NCT ID: NCT01719913 Completed - Metabolic Diseases Clinical Trials

The Effect of Gluten on Gut Microbiome and Metabolic Health.

3G
Start date: October 2012
Phase: N/A
Study type: Interventional

Objective: To identify how specific changes of the gluten content in the diet affect the host-gut microbiome interactions with implications for metabolic health. Design: A randomized, controlled, single-blinded, cross-over intervention trial consisting of two 8-week interventions periods, separated by a 6-week wash-out period. A total number of 60 participants will be included. Intervention: low vs high gluten intake.

NCT ID: NCT01714622 Withdrawn - Clinical trials for Gastric Cancer With Metabolic Syndrome or Metabolic Disease

Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin Resistance

Start date: October 2012
Phase:
Study type: Observational

Gastric cancer is still one of the most common malignance in Korea. Because of the popularity of regular check ups, early detection of gastric cancer has increased, consequently, the survival of the patients also has increased. In this reason, the interest of outcomes after gastrectomy for gastric cancer move survival only to quality of life of these patients. Although the definition of metabolic syndrome is various, but it is normally accepted as a state that insulin resistance or glucose intolerance combined with hypertension or hyperlipidemia or obesity. Metabolic syndrome is a worldwide health problem, and the treatment is modification of life style, weight loss and medication. However, in most of the patients metabolic syndrome is considered not curable disease. Recent studies have shown that some bariatric surgery offers not only control the overweight but also metabolic syndrome. The exact mechanism is still unknown but decreased gastric volume and intestinal bypass itself seemed to play an important role to improve metabolic syndrome over just decreased weight. For treating gastric cancer, gastrectomy is essential and the extent of gastrectomy is varied subtotal and total gastrectomy according to the location of tumor. Also, reconstruction type is varied gastroduodenostomy and Roux-en-Y gastrojejunostomy after subtotal gastrectomy, esophagojejunostomy after total gastrectomy. This kind of operation for gastric cancer lead decreased gastric volume and/or intestinal bypass, which means this operation could lead similar effect of bariatric surgery. Already, there have been several retrospective reports that metabolic syndrome or diabetes was improved after gastrectomy for gastric cancer but no prospective study about this subject yet in Korea. The purpose of this study is that evaluating the degree of improvement of metabolic syndrome after gastrectomy for gastric cancer, and analyze the differences between the type of operation.

NCT ID: NCT01708681 Completed - Clinical trials for Glucose Metabolism Disorders

Lean Seafood Intake and Postprandial Metabolism

LeSIP
Start date: October 2012
Phase: N/A
Study type: Interventional

Despite numerous studies of meal components in humans, little is still known about how different meals influence on metabolism. The purpose of this study is to a gain knowledge of how a balanced test meal with either lean seafood (example:cod) or meat as the main protein source will: 1. affect the postprandial metabolism acutely (test-meal at beginning of the study) 2. affect the postprandial metabolism after 4 weeks controlled intervention (test meal at end of intervention period) 3. affect gut microbiota composition

NCT ID: NCT01705782 Completed - Inflammation Clinical Trials

The Effects of Amino Acid Supplement During Acute Inflammation.

Start date: October 2012
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate the metabolic effects during acute inflammation with and without the nutritional supplement of amino acids. E. Coli Endotoxin (LPS, lipopolysaccharide) is used to initiate an inflammatory response. The study is an interventional randomized placebo study including 8 healthy male subjects. Each subject participates 3 times (different days) and are given one of following interventions: - Placebo (NaCl) - Endotoxin, US standard reference E.Coli + Placebo (NaCl) - Endotoxin, US standard reference E.Coli + Amino acids (intravenously) It is our hypothesis that the nutritional intervention during acute inflammation plays an important role in lipid and protein metabolism.

NCT ID: NCT01692860 Completed - Sarcopenia Clinical Trials

Effects of Milk Protein Concentrate on Overall Health During Weight Loss in Overweight/Obese Adults

S28
Start date: January 2012
Phase: N/A
Study type: Interventional

. The purpose of this study is to examine the effects of eating a larger amount of dairy-based protein on risk factors for metabolic syndrome

NCT ID: NCT01686828 Completed - Obesity Clinical Trials

T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin

T-IR
Start date: June 2013
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this research study is to understand the effects of testosterone and estrogen on the body's response to the hormone insulin.

NCT ID: NCT01682343 Completed - Clinical trials for Nutritional and Metabolic Diseases

Effect of High-calcium Intake on Appetite, Insulinemia and Incretins

Start date: May 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the appetite, insulin and incretin hormone responses to a high-calcium meal.

NCT ID: NCT01681173 Completed - Obesity Clinical Trials

OPTIFIT-Optimal Fiber Trial for Diabetes Prevention

Start date: May 2010
Phase: N/A
Study type: Interventional

High intake of insoluble fiber is strongly associated with a reduced incidence of diabetes and cardiovascular events in prospective observation studies. Our primary objective is to compare a life style diabetes prevention program(PRAEDIAS) with and without added insoluble fibers in its effectiveness to prevent incident diabetes type 2 in high risk individuals with impaired glucose tolerance. Subjects with IGT not willing to participate in the intervention will be used as independent controls. Secondary aims are to identify mechanisms of action with regard to body composition, anti-inflammatory and metabolic effects of fibers. We propose a randomized, prospective intervention study. The results will be of general relevance for guidance of fiber intake in the population and will help the food industry to design healthy high fiber foods. Fiber can be added at low cost to numerous foods. Increased fiber intake may therefore provide a simple non-cognitive prevention strategy effective at the population level.

NCT ID: NCT01668836 Recruiting - Clinical trials for Lipid Metabolism Disorders

Influence of Caloric Restriction and Resveratrol in the Sirtuin System in Women and Men Aged 55 to 65 Years

Start date: August 2012
Phase: N/A
Study type: Interventional

Women have a natural protection that gives them greater longevity. One hypothesis most commonly used is the estrogen protection in the premenopausal period. However many studies of various forms of hormone replacement therapy proved ineffective in promoting additional protection for women. Thus, it is discussed other ways of protection associated with longevity in women. Of these, the sirtuin system was found in several animal studies to be associated with longevity. This system also showed, through the involvement of several metabolic pathways, an important protection against the process of atherosclerosis. But the activity of this system in humans is unknown and if it is more active in women than in men. The study's main objectives are to analyze this system in healthy 24 women and 24 men aged 55 to 65 years, and their influence on the main metabolic pathways related to longevity and the process of atherosclerosis. The research protocol includes analysis of the influence of sirtuin (SIRT1) in vascular reactivity, lipid profile, antioxidant capacity, markers of inflammation and homeostasis, before and after the interventions with caloric restriction or resveratrol administration. It is expected of this study mechanistic conclusion for longevity and possible clinical applications in the mechanism of atherosclerosis prevention.